E2 ModerateModerate confidencePEM ?Cross-SectionalPeer-reviewedMachine draft
Dysautonomia and small fiber neuropathy in post-COVID condition and Chronic Fatigue Syndrome.
Azcue, N, Del Pino, R, Acera, M et al. · Journal of translational medicine · 2023 · DOI
Quick Summary
This study compared how the nervous system works differently in people with ME/CFS, people with long COVID, and healthy people. Researchers tested heart rate responses, sweating patterns, and how nerves respond to temperature. They found that people with ME/CFS had more severe problems with heart rate regulation and nerve fiber damage than those with long COVID, and both groups had more problems than healthy controls.
Why It Matters
This study provides objective biomarkers—autonomic dysfunction and small fiber neuropathy—that may help explain why ME/CFS patients experience fatigue, brain fog, and orthostatic symptoms. By comparing ME/CFS directly to post-COVID and healthy controls, it clarifies which features are specific to ME/CFS versus shared post-viral presentations, potentially supporting better diagnostic and treatment approaches.
Observed Findings
- ME/CFS patients had significantly higher resting heart rates than post-COVID patients and healthy controls (Kruskal-Wallis H = 18.3; p ≤ .001).
- Postural Orthostatic Tachycardia Syndrome (POTS) was present in 31% of ME/CFS patients versus 13.8% of post-COVID patients.
- Pathological Sudoscan results in palms occurred in 34% of ME/CFS versus 19.5% of post-COVID patients, suggesting non-length-dependent small fiber neuropathy.
- Heat stimulus response latency was significantly prolonged in ME/CFS compared to controls, indicating unmyelinated fiber damage (H = 23.6; p ≤ .01).
- Lower parasympathetic nervous system activation was associated with worse cognitive performance across both syndromes.
Inferred Conclusions
- ME/CFS involves more severe autonomic dysfunction and small fiber neuropathy than post-COVID condition, with POTS and heat-evoked potential abnormalities as key distinguishing features.
- Small fiber neuropathy in ME/CFS follows a non-length-dependent pattern (upper extremity predominance) rather than the typical length-dependent distribution.
- Autonomic dysfunction, particularly reduced parasympathetic tone, may mechanistically contribute to cognitive impairment in both ME/CFS and post-COVID condition.
- Both syndromes share autonomic dysregulation characterized by inappropriate resting tachycardia, but ME/CFS severity is quantitatively greater.
What This Study Does Not Prove
This cross-sectional design cannot establish causation or determine whether autonomic and neuropathic abnormalities cause symptoms or result from them. The study does not prove these markers are disease-defining or would be present in all ME/CFS patients, as findings reflect group averages with individual variation. Long-term progression and treatment response are not addressed.
Tags
Symptom:Cognitive DysfunctionOrthostatic IntoleranceFatigue
Biomarker:Neuroimaging
Phenotype:Long COVID Overlap
Method Flag:PEM Not DefinedExploratory OnlyStrong Phenotyping